Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment
November 3, 2021Research and Development
Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …
Covid jabs more effective than virus at preventing infection
November 3, 2021Research and Development
A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …
Beverley Carr appointed Chief Business Officer for Amphista Therapeutics
November 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments
Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor
November 2, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify
Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
BioNet and BIA Separations collaborate on development of mRNA vaccines
November 2, 2021Manufacturing and Production
BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …
Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre
November 2, 2021Manufacturing and Production
The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …
Dunad Therapeutics and Novartis enter partnership to develop protein therapies
November 2, 2021Manufacturing and Production
Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …
FDA approve Novartis’ Scemblix to treat leukaemia
November 2, 2021Manufacturing and Production
Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …
Skin patch COVID vaccine may prove more effective than injections
November 1, 2021Sales and Marketing
A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …
China says US COVID origins report lacks credibility
November 1, 2021Sales and Marketing
A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and …
FDA issue Pfizer vaccine emergency clearance for children, and delay Moderna
November 1, 2021Sales and Marketing
The FDA has informed Moderna that it needs more time to review the company’s COVID vaccine in children aged 12 …
Study reveals high efficacy of Sputnik V in protecting aged 60+ against COVID
November 1, 2021Sales and Marketing
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced the results of a real world study by …
Gilead collaborate with Merck for first-line triple negative breast cancer trial
October 29, 2021Medical Communications
Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …
Fluvoxamine effective in reducing hospitalisation in COVID-19 patients
October 29, 2021Medical Communications
A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …
FDA approve Susvimo for wet age-related macular degeneration
October 29, 2021Medical Communications
Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …
XBiotech to launch novel therapy for stroke patients in US
October 29, 2021Medical Communications
Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Human™ antibody therapy for reducing brain injury after stroke, …
Angel Pharmaceuticals receives IND approval for Phase 1/1b Inhibitor in China
October 28, 2021Business Services
Angel Pharmaceuticals has received approval for their IND application, from the Center for Drug Evaluation (CDE) of the China National …
Serial radiation therapy safe as alternative treatment for kidney cancer
October 28, 2021Business Services
The University of Texas MD Anderson Cancer Center has reported that Serial radiation therapy as monotherapy is a safe and …
First long-acting HIV-treatment to be distributed in European countries
October 28, 2021Business Services
ViiV Healthcare, the global specialist HIV company, have presented positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine), the first …
FDA approves Phase II clinical trial of combination treatment for COVID-19
October 28, 2021Business Services
The FDA has approved Vitti Labs’ Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
